February 5, 2018
The Juvenile Diabetes Research Foundation (JDRF) and Massachusetts-based Cam Med, a company specializing in microfluidic-based drug delivery technologies, announced a partnership today focused on development of a thin, flexible, patch-based insulin pump for artificial pancreas systems.
"JDRF is excited to partner with Cam Med on improving insulin delivery hardware,” Jaime Giraldo, program...
January 2, 2018
Using an artificial pancreas (closed-loop control system) could make it easier for adolescents with Type 1 diabetes to participate in intensive outdoor physical activities, according to a study published in Diabetes Care.
The study, which had participants ski or snowboard for five days, found that subjects who used an artificial pancreas maintained a healthy blood sugar level more of the time...
December 18, 2017
Milpitas, California-based diabetes management device maker Bigfoot Biomedical has raised $37 million in Series B funding in a round co-led by funds from Janus Henderson Investors and Quadrant Capital Advisors. Additional participants included Cormorant Asset Management, Senvest Capital Inc., Senvest Management LLC, Visionnaire Ventures, JDRF T1D Fund, and T1D Exchange.
August 21, 2017
IBM and JDRF, a global organization funding Type 1 diabetes research, are joining forces. The collaboration will develop machine learning methods and use them to analyze years of Type 1 research data to pinpoint the factors that can contribute to the onset of the condition in children.
Type 1 diabetes -- T1D for short -- affects about 1.25 million Americans, and to date does not have a cure....
May 12, 2017
A new partnership in the diabetes space could bring the promise of an artificial pancreas closer to reality. Senseonics, a Germantown, Maryland company working on a pill-sized, implantable continuous glucose monitor that can last 90 days without needing replacement, will work with digital, personalized medicine company TypeZero Technologies on a project to integrate readings from Senseonics...
October 11, 2016
Patients Pending, a London-based health startup founded by one of the co-creators of Skype and his brother, has announced that it will follow up its Timesulin insulin pen cap with a Bluetooth-connected insulin pen cap, which the company hopes will help create smart dosing systems for patients with Type 1 diabetes who don’t use an insulin pump.
“Our hypothesis has been, so much of the investment...
October 6, 2016
Boston-based nonprofit T1D Exchange has announced its intentions to make a multi-million dollar investment in automated insulin delivery technologies, the smart algorithms that serve as the bridge between CGMs and insulin pumps in the quest to create an artificial pancreas.
“Type 1 diabetes is a disease that, since the invention of artificial insulin back in 1921, still plagues us because...
November 11, 2015
When Kenneth Stack's son was diagnosed with Type 1 diabetes just before his fifth birthday, the doctor told Stack he was just a few years too early for a major medical breakthrough.
"I remember, trying to make sense of all of this, the doctor saying 'In three years, we’ll have perfected the artificial pancreas and you won’t have to worry about this'," Stack recalled at a panel discussion at the...
September 23, 2015
Glooko and Joslin's HypoMap
Joslin Diabetes Center is running a small trial to pilot test a mobile health app and an online nutrition education platform for people with Type 1 diabetes, according to a ClinicalTrials.gov posting.
The web platform will help educate patients about how to optimize their glucose and analyze their after-meal behavior. The app will facilitate data logging to help...
September 3, 2014
Sanofi Diabetes, a division of Sanofi-Aventis, has launched a new mobile game for iOS and Android phones in the United Kingdom. The game, called Mission T1D, is meant to be educational, to teach children as well as their parents, caregivers, and friends about Type 1 diabetes.
"Children with diabetes and their families face many challenges in their daily lives as they care for a very complex life-...